Literature DB >> 27196363

Synthesis of enantiomerically pure [14 C]-labelled morpholine derivatives for a class of trace amine-associate receptor 1 agonists.

Martin R Edelmann1, Thomas Hartung1, René Trussardi1, Hans Iding1, Guido Galley1, Philippe Pflieger1, Roger D Norcross1.   

Abstract

Various agonists of the trace amine-associate receptor 1, under consideration as potential clinical development candidates, were labelled with carbon-14 for use in preclinical in vitro and in vivo drug metabolism studies. Herein, the [14 C]-radiosynthesis of 2-phenyl-substituted morpholines 1 is described. After evaluating and optimizing different synthetic routes, 4-iodonitrobenzene 3 was selected as starting material for the 14-step synthesis. Incorporation of carbon-14 into the acetyl moiety allowed a safe and efficient synthesis of [14 C]-labelled 4-nitroacetophenone 2 in five steps and 38% yield. Further transformation of 2 to the target compounds 1 was achieved in a 9-step synthesis. In a representative example, [14 C]-labelled 1 was obtained in an overall yield of 11% and was isolated in >99% radiochemical purity and a specific activity of 47 mCi/mmol.
Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  TAAR1; biocatalysis; carbon-14; cyanation; enantioselective reduction; radiosynthesis

Mesh:

Substances:

Year:  2016        PMID: 27196363     DOI: 10.1002/jlcr.3403

Source DB:  PubMed          Journal:  J Labelled Comp Radiopharm        ISSN: 0362-4803            Impact factor:   1.921


  2 in total

1.  A Spontaneous Mutation in Taar1 Impacts Methamphetamine-Related Traits Exclusively in DBA/2 Mice from a Single Vendor.

Authors:  Cheryl Reed; Harue Baba; Zhen Zhu; Jason Erk; John R Mootz; Nicholas M Varra; Robert W Williams; Tamara J Phillips
Journal:  Front Pharmacol       Date:  2018-01-22       Impact factor: 5.810

Review 2.  Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies.

Authors:  Nina Dedic; Heather Dworak; Courtney Zeni; Grazia Rutigliano; Oliver D Howes
Journal:  Int J Mol Sci       Date:  2021-12-07       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.